Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
Cash from Financing Activities
Phathom Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
Cash from Financing Activities
$367.6m
|
CAGR 3-Years
48%
|
CAGR 5-Years
187%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Financing Activities
-$15.8B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-7%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Financing Activities
-$9.4B
|
CAGR 3-Years
-101%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-24%
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Financing Activities
$26.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Financing Activities
-$4.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
2%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Financing Activities
$3.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Phathom Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
367.6m
USD
Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Cash from Financing Activities amounts to 367.6m USD.
What is Phathom Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
187%
Over the last year, the Cash from Financing Activities growth was 206%. The average annual Cash from Financing Activities growth rates for Phathom Pharmaceuticals Inc have been 48% over the past three years , 187% over the past five years .